Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$37.53M-4.4%$38.52M-5.8%$38.63M-12.4%$38.83M-16.6%$39.27M-19.9%
$15.79M-3.5%$16.52M-1.4%$16.57M-8.7%$16.57M-13.3%$16.36M-18.5%
$21.75M-5.1%$22M-8.9%$22.06M-14.9%$22.26M-19.0%$22.92M-20.9%
57.9%-0.4pp57.1%-1.9pp57.1%-1.7pp57.3%-1.7pp58.4%-0.7pp
$668K-4.8%$668K-17.9%$577K-31.2%$582K-27.7%$702K+2.8%
$2.05M+7.9%$2.01M+9.0%$1.98M+10.2%$1.94M+11.5%
$7.88M+0.6%$7.87M-8.8%$7.86M-16.6%$7.85M-23.2%
$10.81M-15.9%$11.4M-16.1%$11.89M-18.6%$12.62M-17.1%$12.86M-20.7%
28.8%-3.9pp29.6%-3.6pp30.8%-2.4pp32.5%-0.2pp32.8%-0.3pp
$0$0$0$0$0
-$208K+45.8%-$120K+31.0%-$655K-$517K-$384K
$13.43M-53.8%$14.11M-53.0%$27.81M-16.4%$28.68M-15.4%$29.05M-16.6%
$2.58M-49.5%$2.82M-45.1%$5.21M-8.1%$5.15M-12.7%$5.12M-16.3%
$10.85M-16.3%$11.29M-18.7%$11.62M-23.8%$12.55M-19.7%$12.96M-20.9%
28.9%-4.1pp29.3%-4.6pp30.1%-4.5pp32.3%-1.2pp33%-0.4pp
$3.38-10.8%$3.48-12.1%$3.54-17.3%$3.75-13.4%$3.79-15.8%
$13.73M-12.5%$14.35M-12.4%$14.81M-16.4%$15.52M-19.9%$15.7M-26.8%
36.6%-3.4pp37.3%-2.8pp38.3%-1.8pp40%-1.6pp40%-3.8pp
$10.81M-15.9%$11.4M-16.1%$11.89M-18.6%$12.62M-17.1%$12.86M-20.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Utah Medical Products's revenue?
Utah Medical Products (UTMD) generated $37.5M in revenue over the trailing twelve months, down 4.4% year over year.
Is Utah Medical Products profitable?
Utah Medical Products reported $10.8M in net income over the trailing twelve months, a 28.9% net margin.
What are Utah Medical Products's profit margins?
Gross margin is 57.9% and operating margin is 28.8%, with a 28.9% net margin.
What is Utah Medical Products's earnings per share?
Utah Medical Products's diluted EPS over the trailing twelve months is $3.38.
Where does Utah Medical Products's income statement data come from?
Every line is extracted from Utah Medical Products's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.